Mucoid Pseudomonas aeruginosa alter sputum viscoelastic properties in patients with non-cystic fibrosis bronchiectasis

V. Alcaraz Serrano (Barcelona, Spain), L. Fernandez Barat (Barcelona, Spain), G. Scioscia (Barcelona, Spain), J. Llorens Llacuna (Barcelona, Spain), E. Gimeno Santos (Barcelona, Spain), B. Herrero Cortina (Barcelona, Spain), N. Vazquez (Barcelona, Spain), A. Gabarrus (Barcelona, Spain), R. Amaro Rodriguez (Barcelona, Spain), R. Menendez (Barcelona, Spain), A. Torres (Barcelona, Spain)

Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Alcaraz Serrano (Barcelona, Spain), L. Fernandez Barat (Barcelona, Spain), G. Scioscia (Barcelona, Spain), J. Llorens Llacuna (Barcelona, Spain), E. Gimeno Santos (Barcelona, Spain), B. Herrero Cortina (Barcelona, Spain), N. Vazquez (Barcelona, Spain), A. Gabarrus (Barcelona, Spain), R. Amaro Rodriguez (Barcelona, Spain), R. Menendez (Barcelona, Spain), A. Torres (Barcelona, Spain). Mucoid Pseudomonas aeruginosa alter sputum viscoelastic properties in patients with non-cystic fibrosis bronchiectasis. 2162

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does Pseudomonas aeruginosa infection alter sputum viscoelastic properties in bronchiectasis patients?
Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques
Year: 2018

Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
Source: Eur Respir J , 49 (4)  1602108; DOI: 10.1183/13993003.02108-2016
Year: 2017




Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis
Source: Eur Respir J 2004; 24 : 631-637
Year: 2004



Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis
Source: Eur Respir J 2011; 37: 553-558
Year: 2011



Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis
Source: ERJ Open Res, 4 (2) 00162-2017; 10.1183/23120541.00162-2017
Year: 2018



Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002

Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2003; 22: 503-506
Year: 2003



Does sputum induction improve Pseudomonas aeruginosa detection in cystic fibrosis?
Source: Eur Respir J 2003; 22: Suppl. 45, 231s
Year: 2003

The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
Source: Eur Respir J 2006; 28: 974-979
Year: 2006



Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2006; 27: 653
Year: 2006


Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
Source: Eur Respir J 2005; 26: 651-656
Year: 2005



Nebulized antibiotics in patients with non-cystic fibrosis bronchiectasis ans chronic pseudomonas aeruginosa infection
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011


Chest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis
Source: ERJ Open Res, 7 (1) 00513-2020; 10.1183/23120541.00513-2020
Year: 2021



Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007



Efficacy of ciprofloxacin against resistant mucoid or non-mucoid P. aeruginosa isolated from non-cystic fibrosis bronchiectasis (NCFB) patients considering lung pharmacokinetics after ciprofloxacin DPI treatment
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Genotypic studies of pseudomonas aeruginosa isolates from adult non-cystic fibrosis bronchiectasis patients
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015

Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients
Source: Eur Respir J, 49 (5) 1601847; 10.1183/13993003.01847-2016
Year: 2017



Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021